🕵️ Attovia Therapeutics, Inc. ($ATTO)
SEC insider & ownership activity, last 12 months · CIK 2058707 · every row links its SEC filing
Insider buy and sell values were withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
6 buyers, value withheld pending verification (21 lots) · 2 sellers, value withheld pending verification (46 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Redmile Group, LLC | 2 | $10.2M | 0 | – | Aug 6, 2026 |
| Frazier Life Sciences XI, L.P. | 1 | $10.0M | 0 | – | Aug 6, 2026 |
| Goldman Sachs Group Inc | 8 | value withheld pending verification | 23 | value withheld pending verification | Aug 6, 2026 |
| Walsh Colin | 8 | value withheld pending verification | 23 | value withheld pending verification | Aug 6, 2026 |
| Venbio Global Strategic Fund IV, L.P. | 1 | $6.5M | 0 | – | Aug 6, 2026 |
| Sanofi | 1 | $5.1M | 0 | – | Aug 6, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Frazier Life Sciences XI, L.P. | 13.5% | 13D | Aug 6, 2026 | filing ↗ | |
| Fhmls XI, L.P. | 13.5% | 13D | Aug 6, 2026 | filing ↗ | |
| Fhmls XI, L.L.C. | 13.5% | 13D | Aug 6, 2026 | filing ↗ | |
| DEEP Track Capital, LP | 7.5% | 13G | Aug 12, 2026 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 7.5% | 13G | Aug 12, 2026 | filing ↗ | |
| David Kroin | 7.5% | 13G | Aug 12, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Sep 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 2, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |